The 3rd Annual Evidence 360 Summit — RWE, Market Access & Pricing, hosted by Veridon Global, will take place on 11–12 March 2027 in Basel, Switzerland, uniting senior decision-makers from pharma, biotech, RWE, HEOR, HTAs, payers, pricing & reimbursement, academia and technology to align evidence generation with real-world access outcomes. A Strategic Shift: From Silos to an...

The 3rd Edition of the Immuno-Oncology & Biomarker Summit, organised by Veridon Global, will convene in Basel, Switzerland on 11–12 March 2027, bringing together senior leaders from pharma, biotech, diagnostics, CROs, academia and technology to advance cancer research, biomarker discovery and precision immuno-oncology. Why Basel? A Strategic Move to Europe’s Pharma Hub Following...

The 2nd Edition Immuno-Oncology & Biomarker Conference, organized by Veridon Global, will take place on 19–20 October 2026 at the Hilton Garden Inn Camden Waterfront in Philadelphia. The conference will bring together leading professionals from pharmaceutical and biotechnology companies, academia, healthcare organizations, CROs, diagnostic companies, and technology providers to...